Literature DB >> 15052487

Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.

Shakhsanam E Aliyeva1, Andrew J Ullmann, Ulrike B Kottler, Martine Frising, Oliver Schwenn.   

Abstract

PURPOSE: To report the histological findings of an eye with severe Aspergillus endophthalmitis after oral treatment with voriconazole. METHODS. Case report.
RESULTS: Histopathological examination revealed no fungal elements in choroidal or retinal vessels. The hyphae were mainly restricted to the vitreal side of the preretinal inflammatory infiltrate. Since the treatment with voriconazole had not been completed at the time of enucleation, the clinical course with potential further limitation or regression of the lesion remains unsettled.
CONCLUSIONS: Endogenous Aspergillus endophthalmitis is a devastating condition often associated with immunodeficiency. The pathogenesis of this entity implies the primary invasion of choroidal and retinal vessels. The lack of antifungal drugs with high blood-ocular permeability results in an extremely poor visual prognosis. Our histological examination indicates promising activity and ocular penetration of the new antifungal agent voriconazole.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15052487     DOI: 10.1007/s00417-004-0901-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

Review 1.  Voriconazole: in the treatment of invasive aspergillosis.

Authors:  Richard B R Muijsers; Karen L Goa; Lesley J Scott
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy.

Authors:  L Laatikainen; M Tuominen; K von Dickhoff
Journal:  Am J Ophthalmol       Date:  1992-02-15       Impact factor: 5.258

3.  Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

Authors:  S Schwartz; D Milatovic; E Thiel
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

4.  Clinically unsuspected bilateral Aspergillus endophthalmitis.

Authors:  W M Myles; S Brownstein; J Deschênes
Journal:  Can J Ophthalmol       Date:  1997-04       Impact factor: 1.882

Review 5.  Treatment outcomes of endogenous fungal endophthalmitis.

Authors:  W E Smiddy
Journal:  Curr Opin Ophthalmol       Date:  1998-06       Impact factor: 3.761

Review 6.  Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.

Authors:  Jorge Garbino; Adriana Ondrusova; Edoardo Baglivo; Daniel Lew; Kathum Bouchuiguir-Wafa; Peter Rohner; Edoardo Baligvo
Journal:  Scand J Infect Dis       Date:  2002

7.  Endogenous Aspergillus endophthalmitis. Clinical features and treatment outcomes.

Authors:  P D Weishaar; H W Flynn; T G Murray; J L Davis; C C Barr; J G Gross; C E Mein; W C McLean; J H Killian
Journal:  Ophthalmology       Date:  1998-01       Impact factor: 12.079

8.  Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.

Authors:  Alain J Romero; Patrick Le Pogamp; Lars-Goran Nilsson; Nolan Wood
Journal:  Clin Pharmacol Ther       Date:  2002-04       Impact factor: 6.875

Review 9.  Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.

Authors:  Andrew J Ullmann
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

10.  Aspergillus terreus endophthalmitis in a patient with chronic lymphocytic leukemia.

Authors:  P H Kalina; R J Campbell
Journal:  Arch Ophthalmol       Date:  1991-01
View more
  4 in total

1.  Endogenous aspergillus endophthalmitis after kidney transplantation.

Authors:  Huan-Huan Cheng; Yong Ding; Min Wu; Cui-Cui Tang; Ri-Jia Zhang; Xiao-Feng Lin; Jin-Tang Xu
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

2.  [Severe Aspergillus endophthalmitis occurring after liver transplantation in an 8-month-old baby].

Authors:  K Pollack; A Naeke; R Fischer; M Kohlhaas; L E Pillunat
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

Review 3.  Etiological agents of fungal endophthalmitis: diagnosis and management.

Authors:  Rubens C Vilela; Luiza Vilela; Priscila Vilela; Raquel Vilela; Roberta Motta; Ana Paula Pôssa; Cirênio de Almeida; Leonel Mendoza
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

4.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.